Hepatitis B Vaccine
European approval announced for Fendrix, GSK's hepatitis B vaccine
Published in Hepatitis Weekly, March 7th, 2005
Fendrix is designed to prevent hepatitis B in patients with renal insufficiency, including specific high-risk groups such as pre-hemodialysis and hemodialysis patients from 15 years of age onwards. Hemodialysis patients' immune response is typically lower than in healthy individuals, therefore a need exists for a vaccine with an improved immunogenicity profile to ensure patients are protected against hepatitis B infections.
Fendrix builds on...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2005-03-07)
More Articles from Hepatitis Weekly
- Diabetes Risk Factors
Hepatitis C virus infection triggers diabetes in liver graft recipients - Diagnostics
Qualitative multiplex RT-PCR offers simultaneous detection of HIV and HCV - Oncology
Low platelet counts denote multicentricity in HCV-related liver cancer - Transplant Medicine
Adefovir resolves drug-resistant hepatitis B after liver transplantation - Vaccine Development
The adjuvant CPG 7909 may allow two-dose hepatitis B vaccine regimens - Allergy and Immunology
Anhydrase II antibody is not a prognostic marker of autoimmune pancreatitis - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
